Ansofaxine has a high affinity for the DA transporter, NE transporter, and serotonin transporter and significantly inhibits the reuptake of DA, NE, and 5-HT, making it a potential TRI for the treatment of MDD (Zhang et al., 2014). The gene discussed is SLC6A3; the disease is major depressive disorder.